Aromatic 2-(Thio)ureidocarboxylic Acids As a New Family of Modulators of Multidrug Resistance-Associated Protein 1: Synthesis, Biological Evaluation, and Structure-Activity Relationships

被引:25
作者
Haecker, Hans-Georg [1 ]
Leyers, Stefan [1 ]
Wiendlocha, Jeanette [1 ]
Guetschow, Michael [1 ]
Wiese, Michael [1 ]
机构
[1] Univ Bonn, Inst Pharmaceut, D-53121 Bonn, Germany
关键词
P-GLYCOPROTEIN; MRP GENE; TRICYCLIC ISOXAZOLES; SELECTIVE INHIBITORS; LEUKOTRIENE C-4; EXPORT PUMP; DRUG-EFFLUX; CELL LINES; ABCB1; MDR1; GLUTATHIONE;
D O I
10.1021/jm900688v
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Four series of aromatic carboxylic acids were prepared with a urea or thiourea moiety at the neighboring position to the carboxyl group and benzene or thiophene as aromatic scaffold. Using a calcein AM assay, these compounds were evaluated as inhibitors of multidrug resistance-associated protein I (MRP1) and selected compounds were examined toward P-glycoprotein (P-gp) as well as breast cancer resistance protein (BCRP) to assess selectivity for MRP1. Two 2-thioureidobenzo[b]-thiophene-3-carboxylic acids (48, 49) were identified as particularly potent inhibitors of MRP1, with IC50 values of around 1 mu M. The structural features of this new family or nontoxic MRP1 inhibitors include a (thio)urea disubstituted with preferentially two alkyl groups at the terminal nitrogen and an additional fused aromatic ring.
引用
收藏
页码:4586 / 4595
页数:10
相关论文
共 79 条
[1]   The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1 [J].
Abdul-Ghani, R ;
Serra, V ;
Györffy, B ;
Jürchott, K ;
Solf, A ;
Dietel, M ;
Schäfer, R .
ONCOGENE, 2006, 25 (12) :1743-1752
[2]   Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding [J].
Aller, Stephen G. ;
Yu, Jodie ;
Ward, Andrew ;
Weng, Yue ;
Chittaboina, Srinivas ;
Zhuo, Rupeng ;
Harrell, Patina M. ;
Trinh, Yenphuong T. ;
Zhang, Qinghai ;
Urbatsch, Ina L. ;
Chang, Geoffrey .
SCIENCE, 2009, 323 (5922) :1718-1722
[3]   Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1) [J].
Bakos, Eva ;
Homolya, Laszlo .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2007, 453 (05) :621-641
[4]   Anticancer multidrug resistance mediated by MRP1: Recent advances in the discovery of reversal agents [J].
Boumendjel, A ;
Baubichon-Cortay, H ;
Trompier, D ;
Perrotton, T ;
Di Pietro, A .
MEDICINAL RESEARCH REVIEWS, 2005, 25 (04) :453-472
[5]   Emtricitabine: Inhibitor and substrate of multidrug resistance associated protein [J].
Bousquet, Laurence ;
Pruvost, Alain ;
Didier, Nathalie ;
Farinotti, Robert ;
Mabondzo, Aloise .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 35 (04) :247-256
[6]  
BURGER H, 1994, LEUKEMIA, V8, P990
[7]   Microwave-mediated heterocyclization to benzimidazo[2,1-b]quinazolin-12(5H)-ones [J].
Carpenter, Richard D. ;
Lam, Kit S. ;
Kurth, Mark J. .
JOURNAL OF ORGANIC CHEMISTRY, 2007, 72 (01) :284-287
[8]   Pharmacophore-based discovery of ligands for drug transporters [J].
Chang, Cheng ;
Ekins, Sean ;
Bahadduri, Praveen ;
Swaan, Peter W. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (12-13) :1431-1450
[9]   Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters [J].
Choudhuri, Supratim ;
Klaassen, Curtis D. .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2006, 25 (04) :231-259
[10]   Multi-Drug-Resistance-Reverting Agents: 2-Aryloxazole and 2-Arylthiazole Derivatives as Potent BCRP or MRP1 Inhibitors [J].
Colabufo, Nicola A. ;
Berardi, Francesco ;
Perrone, Maria Grazia ;
Cantore, Mariangela ;
Contino, Marialessandra ;
Inglese, Carmela ;
Niso, Mauro ;
Perrone, Roberto .
CHEMMEDCHEM, 2009, 4 (02) :188-195